UCB agrees to acquire Ra Pharmaceuticals for $2.5bn in cash
Founded in 2008, Ra Pharma is engaged in developing therapeutics for the treatment of diseases caused by uncontrolled…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Oct 19
Founded in 2008, Ra Pharma is engaged in developing therapeutics for the treatment of diseases caused by uncontrolled…
01 Oct 19
The transaction is expected to further strengthen Sobi’s position in haematology and orphan diseases and expand its presence…
04 Sep 19
HSC becomes a wholly-owned subsidiary of Children's National, which includes a paediatric hospital, outpatient therapy centre, skilled nursing…
03 Sep 19
The offer which would expire by 3 September 2019 has been extended until 1 October 2019, keeping all…